Document is current
Any future updates will be listed below
-
Authors
Garcia-Cabau, Carla https://orcid.org/0000-0003-0533-0642
Bartomeu, Anna
Tesei, Giulio https://orcid.org/0000-0003-4339-4460
Cheung, Kai Chit
Pose-Utrilla, Julia https://orcid.org/0000-0002-5009-344X
Picó, Sara
Balaceanu, Andreea
Duran-Arqué, Berta
Fernández-Alfara, Marcos
Martín, Judit
De Pace, Cesare https://orcid.org/0009-0008-8059-6604
Ruiz-Pérez, Lorena
García, Jesús https://orcid.org/0000-0003-2961-9790
Battaglia, Giuseppe
Lucas, José J. https://orcid.org/0000-0003-1597-3916
Hervás, Rubén
Lindorff-Larsen, Kresten https://orcid.org/0000-0002-4750-6039
Méndez, Raúl https://orcid.org/0000-0002-1952-6905
Salvatella, Xavier https://orcid.org/0000-0002-8371-4185
- License Information
-
More Information
Article History
Received: 9 March 2023
Accepted: 25 October 2024
First Online: 4 December 2024
Competing interests
: K.L.-L. holds stock options in and is a consultant for Peptone. X.S. is a scientific founder and advisor of Nuage Therapeutics. All other authors declare no competing interests.
